- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
ASTM Market Currents
more »
-
March 9 Shares of Aastrom Biosciences (ASTM) come off a trading halt up 20.5% after the company says it landed a $40M private placement for its Series B convertible stock that helps it raise capital without diluting common stock shareholders for 5 years.
Comment![On the Move, Healthcare]
ASTM in Focus
more »
ASTM Related Articles
more »
ASTM News
more »
-
at MarketWatch.com (Jan 4, 2012)
-
at MarketWatch.com (Jul 13, 2011)
-
at MarketWatch.com (May 31, 2011)
-
at MarketWatch.com (May 2, 2011)
-
at MarketWatch.com (Apr 4, 2011)
ASTM Press Releases and Filings
more »
-
GlobeNewswire (May 17, 2012)
-
GlobeNewswire (May 10, 2012)
-
GlobeNewswire (May 9, 2012)
-
GlobeNewswire (May 7, 2012)
-
GlobeNewswire (May 7, 2012)
ASTM Latest Transcript
more »
-
Fri, Feb 8, 2008
ASTM Cramer
more »
Currently, there are no Cramer articles on ASTM.
ASTM Instablog posts
more »
ASTM vs. ETF Alternatives
Company Description
We are a regenerative medicine company (a medical area that focuses on developing therapies that regenerate damaged or diseased tissues or organs) that incorporated in 1989 and focuses on the clinical development of autologous cell products (cells collected from a patient and returned to that... More
